Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

doi:10.3748/wjg.v20.i31.10984

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 31

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6323)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

472

WORD

579

HTML

2910

Figures (1-2)

123

Tables (1-6)

122

Sum=4206

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1113

Download

1004

Sum=2117

Aug 21, 2014 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Aug 21, 2014; 20(31): 10984-10993
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10984

Table 3 Rates of dose modification n (%)

	All genotypes		P value	OR (95%CI)	Genotype 1		P value	OR (95%CI)
	< 60 yr(n = 4558)	≥ 60 yr(n = 301)		OR (95%CI)	< 60 yr(n = 2614)	≥ 60 yr(n = 245)	P value	OR (95%CI)
No dose reduction	3933 (86.3)	208 (69.1)	P value	0.000	2.814 (2.172-3.644)	2204 (84.3)	166 (67.8)	0.000	2.558 (1.918-3.412)
Reduction of RBV	286 (6.3)	55 (18.3)	0.000	1.827 (1.560-2.140)	190 (7.3)	47 (19.2)	0.000	1.74 (1.460-2.074)
Reduction of	224 (4.9)	20 (6.6)	0.183		129 (4.9)	17 (6.9)	0.173
pegINF α2a	224 (4.9)	20 (6.6)	0.183		129 (4.9)	17 (6.9)	0.173
Reduction of RBV and pegINF α2a	115 (2.5)	18 (6.0)	0.001	1.349 (1.138-1.600)	91 (3.5)	15 (6.1)	0.039	1.218 (1.010-1.470)

Rates of dose modification: Comparison of patients < 60 years vs≥ 60 years with chronic hepatitis C. RBV: Ribavirin; pegIFN: Pegylated interferon.

Citation: Roeder C, Jordan S, Schulze zur Wiesch J, Pfeiffer-Vornkahl H, Hueppe D, Mauss S, Zehnter E, Stoll S, Alshuth U, Lohse AW, Lueth S. Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection. World J Gastroenterol 2014; 20(31): 10984-10993
URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10984.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i31.10984